Clinical Trials · NCT01226966
Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 3,152
- Start date
- Sep 2010
- Locations
- 1 site, France
- Primary endpoint
- Percentage of patients still in liraglutide treatment and having a HbA1c (glycosylated haemoglobin) value below 7.0%